Wayne-based Teleflex, a leading global provider for healthcare supplies and services, recently completed the purchase of Z-Medica, the manufacturer of hemostatic products, for $500 million at closing.
An additional $25 million will be paid upon the achievement of certain commercial milestones.
“Teleflex’s strategy is to invest in innovative products and technologies that can meaningfully enhance clinical efficacy, patient safety and comfort, reduce complications and lower the overall cost of care,” Liam Kelly, Teleflex chairman, president and CEO, said. “The acquisition of Z-Medica, an industry leading provider of hemostatic devices, enables Teleflex to leverage strength in the hospital, EMS, and military call points, with differentiated products that complement the EZ-IO and EZPLAZ product portfolio.”
Z-Medica manufacturers products for hemorrhage control for a global market. It sells products under the Combat Gauze, QuikClot, and QuikClot Control+ brands to emergency departments, the military, hospitals for trauma surgery, and EMS.
The gauze products impregnated with kaolin work by accelerating the body’s natural clotting ability.
QuikClot Control+ is for temporary control of Class III or Class IV bleeding in internal organs.
“We are excited to join the Teleflex organization, which shares our vision for making our products the standard of care for the treatment of hemorrhage control,” Z-Medica President and CEO Eric Compton said.